Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07252947 · ClinicalTrials.gov registry record · NA
Stress and Anxiety Effects on Valuation
A NA study of Reward Value Level, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT07252947: Recruiting NA study of Reward Value Level, sponsored by NYU Langone Health.
NCT07252947 is a NA study of Reward Value Level that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07252947, a NA study of Reward Value Level, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand how stress, anxiety, and negative affect change learning and decision-making processes. The primary objective is to assess two forms of decision-making-reward adaptation and emotion prediction errors-differ as a function of stress and anxiety. The secondary objectives are to assess how individual differences measured in our studies relate to these decision variables.
Primary Outcome
Measured as participants' willingness-to-pay ($) for snack foods across the behavioral task. (Aims 1 and 4).
Conditions Studied
Interventions
- BEHAVIORAL Socially Evaluated Cold Pressor Task (SECPT)
- BEHAVIORAL Non-Stressful Control Task
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-12-18 |
| Est. Completion | 2028-11-07 |
| Phase | NA |
What NCT07252947 shows while recruiting
NCT07252947 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Reward Value Level appearing as the primary indexed condition, and to 2 interventions - of which Socially Evaluated Cold Pressor Task (SECPT) is the first listed.
NCT07252947 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07252947 about?
NCT07252947 is a clinical study titled "Stress and Anxiety Effects on Valuation". The purpose of this study is to understand how stress, anxiety, and negative affect change learning and decision-making processes. The primary objective is to assess two forms of decision-making-reward adaptation and emotion prediction errors-differ as a function of stress and anxiety. The secondary...
What is the current status of trial NCT07252947?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-12-18. Estimated completion is 2028-11-07.
What conditions does trial NCT07252947 study?
This clinical trial studies the following conditions: Reward Value Level.
What interventions are being tested in trial NCT07252947?
The interventions under investigation include: Socially Evaluated Cold Pressor Task (SECPT) (BEHAVIORAL), Non-Stressful Control Task (BEHAVIORAL).
Who is sponsoring clinical trial NCT07252947?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07252947 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07252947's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI